Optimal Injection Interval for Intra-Detrusor Botulinum Toxin

The goal of this clinical trial is to see if patients deciding their own follow up times can increase the effectiveness of botulinum toxin (BTX or "Botox") injection for overactive bladder (OAB). The main questions it aims to answer are: * Does the time between repeat injections differ from the 6-month standard when it is based on patient symptoms alone? * Does symptom control or patient satisfaction change when patients control their own follow up times? Participants will undergo standard botulinum toxin injection into the bladder for OAB treatment and will then be randomly assigned to follow up either at a standard 6-month interval or whenever they feel their symptoms return.

NCT Number	NCT06483217
Lead Sponsor	Louisiana State University Health Sciences Center in New Orleans
Conditions	Overactive Bladder, Urinary Urgency, Urinary Incontinence, Urge Urinary Incontinence
Enrollment	100 participants
Start Date	2024-07
Primary Completion	2025-07 (estimated)
Study Completion	2025-10 (estimated)
Updated on ClinicalTrials.gov	2024-07-17